Gene therapy methods /
This volume in the prestigious Methods in Enzymology series discusses methods currently used in preclinical and clinical gene therapy. Subjects covered in this book, such as the use of adeno-associated virus delivery for treatment of Parkinson's disease, are topical and are presented in the met...
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
San Diego, Calif. :
Academic Press,
�2002.
|
Colección: | Methods in enzymology ;
volume 346. |
Temas: | |
Acceso en línea: | Texto completo Texto completo Texto completo |
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | SCIDIR_ocn166230390 | ||
003 | OCoLC | ||
005 | 20231117015042.0 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 070821s2002 caua ob 001 0 eng d | ||
040 | |a N$T |b eng |e pn |c N$T |d YDXCP |d OCLCQ |d CUSER |d IDEBK |d E7B |d OCLCQ |d COF |d OCLCQ |d AZU |d BAKER |d MERUC |d OCLCQ |d OCLCO |d OCLCQ |d GBVCP |d OPELS |d OCLCF |d DEBBG |d KUK |d OCLCQ |d EBLCP |d VVL |d OCLCQ |d OCLCO |d OCLCA |d BUF |d OCLCO |d ANS |d ESU |d SOI |d OCLCO |d OCLCQ |d OCLCA |d CUV |d SCB |d OCLCQ |d INARC |d OCLCQ |d CS1 |d OCLCO |d OCLCQ |d OCLCO | ||
019 | |a 56578754 |a 170957971 |a 326640737 |a 648270223 |a 742283835 |a 808616162 |a 814451481 |a 823106983 |a 823827218 |a 823896713 |a 824088768 |a 824135153 |a 1027379191 |a 1125441878 |a 1244795707 | ||
020 | |a 9781281011237 | ||
020 | |a 1281011231 | ||
020 | |a 9780080496948 |q (electronic bk.) | ||
020 | |a 0080496946 |q (electronic bk.) | ||
020 | |z 0121822478 |q (print) | ||
020 | |z 9780121822477 |q (print) | ||
035 | |a (OCoLC)166230390 |z (OCoLC)56578754 |z (OCoLC)170957971 |z (OCoLC)326640737 |z (OCoLC)648270223 |z (OCoLC)742283835 |z (OCoLC)808616162 |z (OCoLC)814451481 |z (OCoLC)823106983 |z (OCoLC)823827218 |z (OCoLC)823896713 |z (OCoLC)824088768 |z (OCoLC)824135153 |z (OCoLC)1027379191 |z (OCoLC)1125441878 |z (OCoLC)1244795707 | ||
050 | 4 | |a QP601 |b .M49eb vol. 346 | |
050 | 4 | |a RB | |
060 | 4 | |a QZ 50 | |
070 | |a QP601 |b .M49 v. 346 | ||
072 | 7 | |a SCI |x 007000 |2 bisacsh | |
072 | 7 | |a PSBZ |2 bicssc | |
082 | 0 | 4 | |a 572/.7 |2 22 |
245 | 0 | 0 | |a Gene therapy methods / |c edited by M. Ian Phillips. |
260 | |a San Diego, Calif. : |b Academic Press, |c �2002. | ||
300 | |a 1 online resource (xl, 728 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a data file | ||
490 | 1 | |a Methods in enzymology, |x 0076-6879 ; |v v. 346 | |
504 | |a Includes bibliographical references and indexes. | ||
505 | 0 | |a Chapter 1. Gene Therapy for Hypertension: The Preclinical Data; Chapter 2. Oligonucleotide-Mediated Site-Directed Gene Repair; Chapter 3. Stabilized Plasmid-Lipid Particles: A Systemic Gene Therapy Vector; Chapter 4. Enhancing Direct in Vivo Transfection with Nuclease Inhibitors and Pulsed Electrical Fields; Chapter 5. Hydrodynamics-Based Transfection: Simple and Efficient Method for Introducing and Expressing Transgenes in Animals by Intravenous Injection of DNAChapter 6. Bioplex Technology: Novel Synthetic Gene Delivery System Based on Peptides Anchored to Nucleic Acids; Chapter 7. Surgical Procedures for Intravascular Delivery of Plasmid DNA to Organs; Chapter 8. Direct Gene Transfer into Mouse Heart; Section II: Adenovirus; Chapter 9. Myoblast-Mediated Gene Transfer for Therapeutic Angiogenesis; Chapter 10. Use of Phage Display to Identify Novel Peptides for Targeted Gene Therapy; Chapter 11. Helper-Dependent Adenoviral VectorsChapter 12. Gene Transfer Methods for Transplantation; Chapter 13. Generation and Growth of Gutted Adenoviral Vectors; Chapter 14. Adenovirus-Mediated Gene Transfer for Cardiovascular and Renal Diseases; Chapter 15. Gene Transfer to Blood Vessels Using Adenoviral Vectors; Chapter 16. Rearrangements in Adenoviral Genomes Mediated by Inverted Repeats; Chapter 17. High-Capacity, Helper-Dependent, "Gutless" AdenoviralVectors for Gene Transfer into Brain; Chapter 18. Gene Therapy Methods in Cardiovascular Diseases; Section III: Adeno-Associated Virus; Chapter 19. Gene Delivery to Cardiac MuscleChapter 20. Recombinant AAV-Mediated Gene Delivery Using Dual Vector Heterodimerization; Chapter 21. Designing and Characterizing Hammerhead Ribozymes for Use in AAV Vector-Mediated Retinal Gene Therapies; Chapter 22. Adeno-Associated Viral Vector-Mediated Gene Therapy of Ischemia-Induced Neuronal Death; Chapter 23. Recombinant Adeno-Associated Viral Vector Production Using Stable Packaging and Producer Cell Lines; Chapter 24. Streamlined Large-Scale Production of Recombinant Adeno-Associated Virus (rAAV) Vectors; Section IV: Lentivirus; Chapter 25. Gene Transfer to the Brain Using Feline Immunodeficiency Virus-Based Lentivirus VectorsChapter 26. Generation of HIV-1 Derived Lentiviral Vectors; Chapter 27. Design, Production, Safety, Evaluation, and Clinical Applications of Nonprimate Lentiviral Vectors; Chapter 28. Gene Transfer to Airway Epithelia Using Feline Immunodeficiency Virus-Based Lentivirus Vectors; Chapter 29. Transduction of a Gene Expression Cassette Using Advanced Generation Lentiviral Vectors; Chapter 30. Construction, Purification, and Characterization of Adenovirus Vectors Expressing Apoptosis- Inducing Transgenes | |
588 | 0 | |a Print version record. | |
520 | |a This volume in the prestigious Methods in Enzymology series discusses methods currently used in preclinical and clinical gene therapy. Subjects covered in this book, such as the use of adeno-associated virus delivery for treatment of Parkinson's disease, are topical and are presented in the methods-oriented style popularized by this series. | ||
650 | 0 | |a Gene therapy. | |
650 | 0 | |a Adenoviruses. | |
650 | 0 | |a Feline immunodeficiency virus. | |
650 | 0 | |a Retroviruses. | |
650 | 0 | |a Lentiviruses. | |
650 | 0 | |a Viruses. | |
650 | 1 | 2 | |a Genetic Therapy |x methods |0 (DNLM)D015316Q000379 |
650 | 2 | |a Genetic Therapy |0 (DNLM)D015316 | |
650 | 2 | |a Immunodeficiency Virus, Feline |0 (DNLM)D016089 | |
650 | 2 | |a Lentivirus |0 (DNLM)D016086 | |
650 | 2 | |a Viruses |0 (DNLM)D014780 | |
650 | 2 | 2 | |a Adenoviridae |0 (DNLM)D000256 |
650 | 2 | 2 | |a Retroviridae |0 (DNLM)D012190 |
650 | 6 | |a Th�erapie g�enique. |0 (CaQQLa)201-0193146 | |
650 | 6 | |a Ad�enovirus. |0 (CaQQLa)201-0061725 | |
650 | 6 | |a Virus de l'immunod�eficience f�eline. |0 (CaQQLa)201-0351018 | |
650 | 6 | |a R�etrovirus. |0 (CaQQLa)201-0088455 | |
650 | 6 | |a Lentivirus. |0 (CaQQLa)201-0264637 | |
650 | 6 | |a Virus. |0 (CaQQLa)201-0078047 | |
650 | 7 | |a SCIENCE |x Life Sciences |x Biochemistry. |2 bisacsh | |
650 | 7 | |a Adenoviruses |2 fast |0 (OCoLC)fst00796586 | |
650 | 7 | |a Feline immunodeficiency virus |2 fast |0 (OCoLC)fst00922557 | |
650 | 7 | |a Gene therapy |2 fast |0 (OCoLC)fst00939638 | |
650 | 7 | |a Lentiviruses |2 fast |0 (OCoLC)fst00996211 | |
650 | 7 | |a Retroviruses |2 fast |0 (OCoLC)fst01096406 | |
650 | 7 | |a Viruses |2 fast |0 (OCoLC)fst01167771 | |
650 | 1 | 7 | |a Gentherapie. |2 gtt |
650 | 7 | |a Biof�isica. |2 larpcal | |
700 | 1 | |a Phillips, M. Ian, |e editor. | |
776 | 0 | 8 | |i Print version: |t Gene therapy methods. |d San Diego, Calif. : Academic Press, �2002 |z 0121822478 |w (OCoLC)49223869 |
830 | 0 | |a Methods in enzymology ; |v volume 346. |x 0076-6879 | |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780121822477 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00766879/346 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00766879 |z Texto completo |